3 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
News 2026-09-28 13:34 UTC
By Robb M. StewartLifecore Biomedical has agreed to be bought by Webster Equity Partners in a transaction valued at up to $663.7 million.The contract manufacturer of syringes and other injectable pharmaceutical products on Monday said it entered a definitive deal that will see an entity affiliated…
News 2026-09-28 12:49 UTC
Lifecore agreed to be acquired by Webster Equity Partners for $6.28 per share in cash plus a non-tradable CVR worth up to $160M, subject to milestones. Closing is expected by end of Q4 2026, pending approvals.Material DetailsContext by AI AnalystThis is a late-stage development culminating in a cha…
News 2026-09-28 12:45 UTC
Deal value is up to $663.7 million if performance milestones are met; closing is targeted for end-Q4 2026.